دورية أكاديمية

Phase II Trial of Nab-Paclitaxel Compared With Docetaxel as First-Line Chemotherapy in Patients With Metastatic Breast Cancer: Final Analysis of Overall Survival

التفاصيل البيبلوغرافية
العنوان: Phase II Trial of Nab-Paclitaxel Compared With Docetaxel as First-Line Chemotherapy in Patients With Metastatic Breast Cancer: Final Analysis of Overall Survival
المؤلفون: Gradishar, William J., Krasnojon, Dimitry, Cheporov, Sergey, Makhson, Anatoly N., Manikhas, Georgiy M., Clawson, Alicia, Bhar, Paul, McGuire, John R., Iglesias, Jose
المصدر: In Clinical Breast Cancer October 2012 12(5):313-321
قاعدة البيانات: ScienceDirect
الوصف
تدمد:15268209
DOI:10.1016/j.clbc.2012.05.001